- Home
- About Us
- Why Red Hot Penny Shares
- Recent Red Hot Issues
- No Obligation Trial
- Free Gifts
- What Our Readers Think
- 3 "Must buy" penny shares for 2010
- URGENT: 'Abandoned Oil' Report
- Current Red Hot Portfolio
- 5 year performance
- About Previous Stock Tips
- 10 Simple Rules For Maximising Your Penny Share Profits
- Why Invest in Penny Shares?
- How successful is AIM?
- How to Manage your Portfolio
- 3 Penny Shares to Watch in 2010
- The £1bn Falkland Oil Gamble
- Biotech & Pharmaceuticals
- Mining & Explorers
- Oil & Gas
- Technology & Software
Your capital is at risk when you invest in shares, so never risk more than you can afford to lose. Past performance and forecasts are not reliable indicators of future results. Shares recommended are small company shares. These can be relatively illiquid and hard to trade making them riskier than other investments. Always seek personal advice if you are unsure about the suitability of any investment.
Profits from share dealing are a form of income and subject to taxation. Tax treatment depends on individual circumstances and may be subject to change in the future.
See Terms and Conditions for full details.
March 2010
(Where you see ">>" you may click for more information on that stock)
| 511% |
 |
Hold | |
| 196% |
 |
Buy | |
| 148% |
 >> |
Hold | |
| 97% |
 |
Buy | |
| 83% |
 |
Buy | |
| 64% |
 >> |
Hold | |
| 46% |
 >> |
Buy | |
| 45% |
 |
Hold | |
| 41% |
 |
Hold | |
| 36% |
 >> |
Buy | |
| 24% |
 |
Buy | |
| 17% |
 >> |
Hold | |
| 16% |
 >> |
Buy | |
| 13% |
 >> |
Buy | |
| 13% |
 |
Buy | |
| 8% |
 >> |
Buy | |
| 3% |
 >> |
Buy | |
| 0% |
 |
Buy | |
| 0% |
 |
Buy | |
| 0% |
 >> |
Buy | |
| 0% |
 >> |
Buy | |
| 0% |
 >> |
Buy | |
| 0% |
 >> |
Buy | |
| -2% |
 |
Buy | |
| -9% |
 >> |
Hold | |
| -14% |
 |
Buy | |
| -18% |
 >> |
Buy | |
| -20% |
 |
Buy | |
| -21% |
 |
Buy | |
| -42% |
 |
Buy | |
| -43% |
 |
Hold | |
| -56% |
 |
Buy |
2010 and 2011 could turn this canny pharmaceutical company into a multi-million pound venture... I'm aiming for AT LEAST a 230% gain in the next 12 months! This company operates in the world of urology and it plans to launch 9 products in 2010.
The company has sold the global rights to their most exciting product and should begin receiving royalties of up to £21m a year towards the end of 2010.
Current RHPS recommendation: BUY UP TO 15p
With royalties set to come in later this year and a host of other products in the pipeline, this is one exciting pharmaceutical penny share. Find out more by clicking through to start your no obligation trial!
